FDA to Refuse Device Imports from Austria Company for CGMP Violations
Care Diagnostica’s devices are subject to import refusal for violations of current good manufacturing practice requirements, said the Food and Drug Administration in a warning letter dated April 23. The Moellesrsdorf, Austria company has 15 days from receipt of FDA’s…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
letter to correct the violations.